BioTech, Industry and Medicare - Connected Health Pulse

Bonfire Analytics Raises Oversubscribed $2M Venture Round to Accelerate Digital Health, Medical Device, & Biotech Adoption Across Healthcare Providers

Healthcare IT Today

FEBRUARY 22, 2024

Healthtech is a burgeoning part of the healthcare industry and has rapidly risen in value. However, a major bottleneck for the healthtech industry is the inability to sell effectively into the healthcare provider and plan markets. physicians, physician groups, hospitals, health systems, etc).

BioTech

BioTech Digital Health HIPAA Medicare

Aduhelm and Alzheimer’s Disease: A Potential Medicare Budget-Buster Puts A Blazing Light on Health Care Costs and Innovation

Health Populi

JUNE 29, 2021

consumers’ bipartisan support for drug price regulation through Medicare negotiation and private/commercial sector adoption. The post Aduhelm and Alzheimer’s Disease: A Potential Medicare Budget-Buster Puts A Blazing Light on Health Care Costs and Innovation appeared first on HealthPopuli.com. and beyond.

Medicare

Medicare Life Science BioTech Pharmaceuticals

Trust in Healthcare is Under Stress in the US and Globally, Edelman Finds

Health Populi

MAY 20, 2021

Nearly eighteen months later, a 2021 Edelman Trust Barometer update finds that consumers’ trust in the health care industry is under stress, too — in the U.S. now, looking at health citizens’ trust in five segments of the health care industry between 2015 and 2021. in the first quarter of 2020. and around the world.

BioTech

BioTech Pharmaceuticals Leadership Medicare

Value-Based Health Care Needs All Stakeholders at the Table – Especially the Patient

Health Populi

MARCH 11, 2021

health care, patient assistance programs, Medicare Advantage plans, and the bundling of proven high-value preventive services into the Affordable Care Act. In the case of Medicare Part D, the drug benefit, Chandra said, “If you’re sick enough to fall into the donut hole, you may have higher mortality.”

Health Policy

Health Policy Medicare Pharmaceuticals Life Science

Global OTC/DTC Infectious Disease Diagnostic Market 2023 to 2027

Digital Health Global

MARCH 14, 2023

Players Include 1DropDiagnostics, Abbott Laboratories, Ador Diagnostics, ADT Biotech and Akonni Biosystems DUBLIN–(BUSINESS WIRE)–The “OTC/DTC Infectious Disease Diagnostics Strategies and Trends for Over the Counter and Direct to Consumer. Industry Participants 4.2 Industry Structure 5 Market Trends 5.1

BioTech

BioTech Medicare Digital Health

The Healthcare and Macro-Economic Impacts of Living with Endemic COVID – Listening to Fitch

Health Populi

JUNE 24, 2021

I welcomed the opportunity to learn from this team’s approach in weaving together the dynamic issues that help us to plan for the long-tail of COVID-19 and its impact on the economy and prospects for the health care industry and health citizens. spends on NASA.

BioTech

BioTech Pharmaceuticals Public Health Telehealth

The New Drug Companies Aren’t Drug Companies At All

Health Populi

JULY 11, 2019

This research organization will develop medicines targeting older adults — which makes sense because Clover Health’s target consumer market is Medicare Advantage beneficiaries.

Life Science

Life Science BioTech Medicare Pharmaceuticals

Infectious Disease Diagnostics Research Revolution 2024: New Report Analyzes OTC and DTC Trends and Strategies Through 2027 – ResearchAndMarkets.com

Digital Health Global

APRIL 5, 2024

A comprehensive and insightful report analyzing these transformative trends has been added to our industry-leading research publication collections. These technical advancements are analyzed for their potential to change current market paradigms and foster a growing and evolving industry. Industry Participants 4.1.1 Testing 3.6.3

BioTech

BioTech Digital Health Medicare Telehealth

The Retail Health Battle Royale in the U.S. – A Week-Long Brainstorm, Day 2 of 5 – Amazon and One Medical

Health Populi

JULY 26, 2022

Iora Health has focused on the Medicare-enrolled population, distinct from ONEM’s target patient market of younger, employed consumers. According to the team’s analysis, Amazon is not yet active in AR/VR, med-tech/biotech, or insurance (but see more on that below via Mike McSherry’s observations).

Primary Care

Primary Care Digital Health BioTech Medicare

The Evolution of Self-Care for Consumers – Learning and Sharing at CHPA

Health Populi

MARCH 19, 2019

Key issues facing the industry in 2019 and into the next few years range from regulation of dietary supplements and the role of CBD in self-care, the omni-channel consumer, ecommerce vs. bricks-and-mortar, trust, and wrestling with consumer privacy. Consumer health went opposite, up 7 points, biotech up 3, insurance up 8, pharma up 6.

BioTech

BioTech Life Science Leadership Medicare

Spring 2019: Healthcare Updates to Know

Advanced Medical Reviews

APRIL 17, 2019

A new season has arrived, and it brings new changes within the healthcare industry. To help keep you informed about these issues and how they may affect you, we’ve compiled the most important industry news. Sharpless is a proponent of big data and previously founded two biotech companies. FDA Commissioner Resigns.

BioTech

BioTech Public Health Medicare

Will Consumers Cross the Cost-and-Trust Chasm Between Prescription Drugs and Hospitals?

Health Populi

OCTOBER 28, 2019

patients’ negative views of the pharmaceutical industry in this study was the opioid epidemic. published by the National Bureau of Economic Research found a close link between electoral politics and Medicare: that is, between legislative processes in the U.S. Physician fees are cited as cost-contributing by only 18% of patients.

Pharmaceuticals

Pharmaceuticals Medical Billing Medicare Mental health

Will Foot Ulcer Treatment Survive Medicare Rollback?

Insulin Nation

DECEMBER 18, 2013

A state-of-the-art wound therapy that prevents amputations is under threat from proposed cuts in Medicare reimbursement rates, according to regenerative medicine experts. However, the impact is already being felt in the industry. Apligraf, pictured here, is a dressing made of living cells used to help heal diabetic foot ulcers.

Medicare

Medicare BioTech Pharmaceuticals

Bonus Features, HLTH Edition – October 11, 2023 – Announcements from Best Buy, General Catalyst, Google Cloud, Microsoft, Walgreens, and more

Healthcare IT Today

OCTOBER 11, 2023

which will partner with 20+ health system partners to guide their transition to value-based care and potentially acquire a health system “where we can demonstrate the blueprint of this transformation for the rest of the industry.” RedHealthy Communications : PR and marketing for biotech, life sciences, and digital health.

Life Science

Life Science EHR BioTech RCM

Pharmaceutical industry rips 'draconian' price negotiation provision

FierceHealthIT

AUGUST 29, 2023

The Biden administration and federal regulators may be taking a victory lap following the unveiling of the Centers for Medicare & Medicaid Services’ (CMS') price negotiations list, but major pl | Critics of President Joe Biden's policies to rein in prices for 10 Medicare Part D drugs believe the policy is "draconian" and will (..)

Pharmaceuticals

Pharmaceuticals BioTech Medicare

Prescription Drug Costs In America Through the Patient Lens, via IQVIA, GoodRx and a New $2 Million Therapy

Health Populi

MAY 8, 2019

In 2018, we saw more incentives to inspire adherence to prescription drug regimens, particularly in Medicare Part D along with increasing focus by pharmacists and providers. For people enrolled in Medicare Part D, 20% faced over $500 in OOP costs. Patients abandon over 20% of new prescriptions when their OOP costs rise above $50.

Medicare

Medicare BioTech Pharmaceuticals Mental health

Rx 2018: A New Era of Specialty Drugs, Telehealth, Mobile Apps and Value, IQVIA Reports

Health Populi

MARCH 13, 2018

Specifically, $19 billion worth of biotech spending will find biosimilar competition starting in 2018 for the first time. We don’t know yet what form that will take, but there is some indication that Dr. Azar is has his sights on some form of prescription drug pricing program, perhaps beginning with Medicare Part B.

Telehealth

Telehealth Pharmaceuticals BioTech Medicare

The Gap Between the Trump Administration’s Promise of Reducing Rx Costs for Consumers and What People Really Want

Health Populi

MAY 14, 2018

What this upward driving curve indicates, from the start of stock trading in the morning until the ring of the closing bell, is that the pharma industry players, both manufacturers and PBMs, were quite delighted with what they heard. ” Ronny Gal, pharma industry analyst at Sanford Bernstein & Co.,

Pharmaceuticals

Pharmaceuticals Medicare Life Science BioTech

Pharma – 2023 Health IT Predictions

Healthcare IT Today

JANUARY 9, 2023

Jesse Cugliotta, Global Industry GTM Lead, Healthcare & Life Sciences at Snowflake. The industry is beginning to invest in and will increase funding into modern data platforms that eliminate technical hurdles and custom built data pipelines to allow data to flow in real-time and deliver on the promise of improved healthcare outcomes.

Health IT

Health IT Pharmaceuticals Drug Development Life Science

The intersection of remote patient monitoring and AI

Healthcare IT News - Telehealth

OCTOBER 25, 2022

She has been involved with more than 20 early-stage biotech and healthcare startups, including ones working on medical devices and digital health. The Centers for Medicare and Medicaid Services is one of the organizations that sets the standard of care in the U.S.

BioTech

BioTech EHR Medicare Interoperability

Prescription Drugs in the Pandemic, Year 2: Pricing Rx and Going Direct-to-Consumer

Health Populi

AUGUST 16, 2021

There is one health care public policy issue that unites U.S. voters across political party: that is the consumer-facing costs of prescription drugs.

Pharmaceuticals

Pharmaceuticals Telehealth BioTech Mental health

Most Americans Across Party ID Favor U.S. Government Negotiation to Lower Rx Drug Costs

Health Populi

MARCH 6, 2019

is prescription drug prices — that they’re too high, that the Federal government should negotiate to lower costs for Medicare enrollees, and that out-of-pocket costs for drugs should be limited. One of the only issues bringing people together in the U.S. ” drugs to come to market, understanding this dynamic.

Pharmaceuticals

Pharmaceuticals Life Science Medicare BioTech

Two-Thirds of Americans Say Healthcare Doesn’t Work Well, in RealClear Politics Poll

Health Populi

MAY 19, 2019

They don’t tend to shop around for health care or be super-engaged in their care, probably because they tend to be older and more likely to be covered by Medicare. They may be threatened by a call for “Medicare for All” given their affection for the program. That’s an interesting conundrum to consider.

Life Science

Life Science BioTech Medicare Medical Billing

Connected Health Pulse

Bonfire Analytics Raises Oversubscribed $2M Venture Round to Accelerate Digital Health, Medical Device, & Biotech Adoption Across Healthcare Providers

Aduhelm and Alzheimer’s Disease: A Potential Medicare Budget-Buster Puts A Blazing Light on Health Care Costs and Innovation

Trending Sources

Trust in Healthcare is Under Stress in the US and Globally, Edelman Finds

Value-Based Health Care Needs All Stakeholders at the Table – Especially the Patient

Global OTC/DTC Infectious Disease Diagnostic Market 2023 to 2027

The Healthcare and Macro-Economic Impacts of Living with Endemic COVID – Listening to Fitch

The New Drug Companies Aren’t Drug Companies At All

Infectious Disease Diagnostics Research Revolution 2024: New Report Analyzes OTC and DTC Trends and Strategies Through 2027 – ResearchAndMarkets.com

The Retail Health Battle Royale in the U.S. – A Week-Long Brainstorm, Day 2 of 5 – Amazon and One Medical

The Evolution of Self-Care for Consumers – Learning and Sharing at CHPA

Spring 2019: Healthcare Updates to Know

Will Consumers Cross the Cost-and-Trust Chasm Between Prescription Drugs and Hospitals?

Will Foot Ulcer Treatment Survive Medicare Rollback?

Bonus Features, HLTH Edition – October 11, 2023 – Announcements from Best Buy, General Catalyst, Google Cloud, Microsoft, Walgreens, and more

Pharmaceutical industry rips 'draconian' price negotiation provision

Prescription Drug Costs In America Through the Patient Lens, via IQVIA, GoodRx and a New $2 Million Therapy

Rx 2018: A New Era of Specialty Drugs, Telehealth, Mobile Apps and Value, IQVIA Reports

The Gap Between the Trump Administration’s Promise of Reducing Rx Costs for Consumers and What People Really Want

Pharma – 2023 Health IT Predictions

The intersection of remote patient monitoring and AI

Prescription Drugs in the Pandemic, Year 2: Pricing Rx and Going Direct-to-Consumer

Most Americans Across Party ID Favor U.S. Government Negotiation to Lower Rx Drug Costs

Two-Thirds of Americans Say Healthcare Doesn’t Work Well, in RealClear Politics Poll

Stay Connected